指南与共识血栓与止血

患者对VTE疾病的价值观与偏好:为美国血液学会指南提供信息的系统综述

Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines.
指南 / 共识 · Blood Adv · 2020-01-01

为 informing 美国血液学会静脉血栓栓塞症(VTE)管理指南,作者系统检索了至2018年4月的文献,纳入定量与定性研究,评估患者对VTE相关健康结局的相对重要性及治疗偏好。结果显示患者更重视降低VTE风险而非治疗潜在危害,且明确偏好口服而非皮下注射药物,证据确定性低至中等。

要点

  • 患者更看重降低VTE风险,而非治疗带来的潜在危害。
  • 患者明确偏好口服药物而非皮下注射药物(中等确定性)。
  • 健康状态价值观的变异可能源于 elicitation 方法差异和人群多样性,而非真实价值观差异。

核心结论

  • 患者整体上更重视降低VTE风险而非治疗潜在危害,并偏好口服药物而非皮下注射药物。

研究设计与样本

  • 系统综述,检索Medline、Embase、Cochrane CENTRAL、PsycINFO和CINAHL从建库至2018年4月,纳入定量和定性研究。
  • 纳入14项定量研究(2465名参与者)描述VTE相关健康状态的相对重要性,另34项定量研究(6424名参与者)和15项定性研究(570名参与者)评估治疗偏好。
  • 采用GRADE方法评级证据确定性,定性研究采用扎根理论主题综合。

主要发现

  • 14项定量研究(2465名参与者)显示VTE相关健康状态对患者生活整体影响为小幅至重要(证据确定性低至中等)。
  • 34项定量研究(6424名参与者)和15项定性研究(570名参与者)显示患者更重视降低VTE风险而非治疗潜在危害(证据确定性低至中等)。
  • 研究提示患者明确偏好口服药物而非皮下注射药物(中等确定性)。

临床怎么用

  • 在VTE管理决策中应纳入患者对降低血栓风险的高度重视及对口服药物的偏好。

局限性

  • 健康状态价值观的观察变异可能源于 elicitation 方法差异和纳入人群多样性,而非真实价值观差异;需探索不同方法导致的变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Values and preferences relate to the importance that patients place on health outcomes (eg, bleeding, having a deep venous thrombosis) and are essential when weighing benefits and harms in guideline recommendations. To inform the American Society of Hematology guidelines for management of venous thromboembolism (VTE) disease, we conducted a systematic review of patients' values and preferences related to VTE. We searched Medline, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature from inception to April of 2018 (PROSPERO-CRD42018094003). We included quantitative and qualitative studies. We followed Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidance for rating the certainty and presenting findings for quantitative research about the relative importance of health outcomes and a grounded theory approach for qualitative thematic synthesis. We identified 14 quantitative studies (2465 participants) describing the relative importance of VTE-related health states in a widely diverse population of patients, showing overall small to important impact on patients' lives (certainty of the evidence from low to moderate). Additionally, evidence from 34 quantitative studies (6424 participants) and 15 qualitative studies (570 participants) revealed that patients put higher value on VTE risk reduction than on the potential harms of the treatment (certainty of evidence from low to moderate). Studies also suggested a clear preference for oral medication over subcutaneous medication (moderate certainty). The observed variability in health state values may be a result of differences in the approaches used to elicit them and the diversity of included populations rather than true variability in values. This finding highlights the necessity to explore the variability induced by different approaches to ascertain values.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Etxeandia-Ikobaltzeta I, Zhang Y, Brundisini F, et al. Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines. Blood Adv. 2020. PMID: 32150612. doi:10.1182/bloodadvances.2019000462

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。